← United States · Coverage record
US · SEC FORM 4
Zivo Bioscience, Inc.
ZIVO · OTC · CIK 0001101026 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
No Form 4 transaction event is present in the current 180-day window.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Latest recorded score
- 40.8
- 41.8
- 41.8
- 41.8
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- +47.2%
- 3M
- +9.7%
- 6M
- +120.8%
- 12M
- -55.8%
Volatility & liquidity
- Volatility
- 152.4%
- Beta
- —
- Avg daily value
- USD 3,029
Valuation
- Market cap
- —
- P/E
- —
Fundamentals
- Profit margin
- —
- ROE
- —
- Industry
- Biotechnology
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 7,977
- Previous report
- 8,019
- Avg daily volume
- 1,137
- Days to cover
- 7.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | Purchase (P) | Common Stock | 100,000 | USD 2.00 | USD 200,000 | SEC filing ↗ |
| 2026-02-27 | YALDOO LAITH L | Purchase (P) | Common Stock | 1,543 | USD 9.72 | USD 14,998 | SEC filing ↗ |
| 2026-02-12 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | Purchase (P) | Common Stock | 20,000 | USD 9.77 | USD 195,400 | SEC filing ↗ |
| 2026-02-10 | YALDOO LAITH L | Purchase (P) | Common Stock | 2,434 | USD 10.27 | USD 24,997 | SEC filing ↗ |
| 2026-01-26 | PAYNE JOHN BERNARD | Purchase (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC filing ↗ |
| 2026-01-26 | Cornell Alison A | Purchase (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC filing ↗ |
| 2026-01-14 | YALDOO LAITH L | Purchase (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC filing ↗ |
| 2026-01-14 | Maggiore Christopher D. | Purchase (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC filing ↗ |
| 2025-11-28 | YALDOO LAITH L | Purchase (P) | Common Stock | 2,777 | USD 9.00 | USD 24,993 | SEC filing ↗ |
| 2025-10-13 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | Purchase (P) | Common Stock | 20,259 | USD 12.34 | USD 249,996 | SEC filing ↗ |
| 2025-10-10 | YALDOO LAITH L | Purchase (P) | Common Stock | 1,659 | USD 12.05 | USD 19,991 | SEC filing ↗ |
| 2025-10-08 | Maggiore Christopher D. | Purchase (P) | Common Stock | 23,682 | USD 12.01 | USD 284,421 | SEC filing ↗ |
| 2025-09-30 | YALDOO LAITH L | Purchase (P) | Common Stock | 15,322 | USD 15.99 | USD 244,999 | SEC filing ↗ |
| 2025-06-13 | YALDOO LAITH L | Purchase (P) | Common Stock | 3,488 | USD 14.33 | USD 49,983 | SEC filing ↗ |
| 2025-01-22 | YALDOO LAITH L | Purchase (P) | Common Stock | 10,080 | USD 17.53 | USD 176,702 | SEC filing ↗ |
Form 4 evidence
9 transaction lines in the latest 365-day window; 80 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | Purchase (P) | Common Stock | 100,000 | USD 2.00 | USD 200,000 | SEC filing ↗ |
| 2026-02-27 | YALDOO LAITH L | Purchase (P) | Common Stock | 1,543 | USD 9.72 | USD 14,998 | SEC filing ↗ |
| 2026-02-12 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | Purchase (P) | Common Stock | 20,000 | USD 9.77 | USD 195,400 | SEC filing ↗ |
Show recent Form 4 evidence (9 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | Purchase (P) | Common Stock | 100,000 | USD 2.00 | USD 200,000 | SEC filing ↗ |
| 2026-02-27 | YALDOO LAITH L | Purchase (P) | Common Stock | 1,543 | USD 9.72 | USD 14,998 | SEC filing ↗ |
| 2026-02-12 | STROME GROUP, INC.; STROME INVESTMENT MANAGEMENT LP; STROME MARK E | Purchase (P) | Common Stock | 20,000 | USD 9.77 | USD 195,400 | SEC filing ↗ |
| 2026-02-10 | YALDOO LAITH L | Purchase (P) | Common Stock | 2,434 | USD 10.27 | USD 24,997 | SEC filing ↗ |
| 2026-01-26 | PAYNE JOHN BERNARD | Purchase (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC filing ↗ |
| 2026-01-26 | Cornell Alison A | Purchase (P) | Common Stock | 11,709 | USD 8.54 | USD 99,995 | SEC filing ↗ |
| 2026-01-14 | YALDOO LAITH L | Purchase (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC filing ↗ |
| 2026-01-14 | Maggiore Christopher D. | Purchase (P) | Common Stock | 1,766 | USD 8.49 | USD 14,993 | SEC filing ↗ |
| 2025-11-28 | YALDOO LAITH L | Purchase (P) | Common Stock | 2,777 | USD 9.00 | USD 24,993 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ZIVO |
| CIK | 0001101026 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| Exchange | OTC |
Data coverage
| Local Form 4 history | 80 transaction lines from 2020-01-03 to 2026-04-17 49 P purchase lines · 1 S sale lines · 30 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.